Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Phase 3

Completed

Conditions: Chronic Renal Failure
Chronic Kidney Disease

Interventions: Biological: Epoetin Hospira
Biological: Epogen Amgen

First Posted Date: 2011-11-17

Last Posted Date: 2018-08-09

Lead Sponsor: Pfizer

Target Recruit Count: 320

Registration Number: NCT01473420

Locations: 🇺🇸
National Institute of Clinical Research, Bakersfield, California, United States
🇺🇸
North America Research Institute, Azusa, California, United States
🇺🇸
Valley Renal Medical Group, Northridge, California, United States

and more 67 locations

A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection

Phase 3

Completed

Conditions: Intra-abdominal Infections

Interventions: Drug: Metronidazole
Drug: Ceftriaxone sodium

First Posted Date: 2011-11-17

Last Posted Date: 2014-01-24

Lead Sponsor: Pfizer

Target Recruit Count: 38

Registration Number: NCT01473836

Locations: 🇯🇵
Iida Municipal Hospital, Iida, Nagano, Japan
🇯🇵
National Hospital Organization Kokura Medical Center, Kitakyushu, Fukuoka, Japan
🇯🇵
Koshigaya Municipal Hospital, Koshigaya, Saitama, Japan

and more 12 locations

A Study Of Gastrointestinal Tolerability Of PF05212389 In Obese Subjects

Phase 1

Withdrawn

Conditions: Obesity

Interventions: Drug: PF 05212389 or placebo

First Posted Date: 2011-11-17

Last Posted Date: 2011-11-17

Lead Sponsor: Pfizer

Registration Number: NCT01472848

A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Phase 3

Completed

Conditions: Chronic Kidney Disease
Chronic Renal Failure

Interventions: Biological: Epogen (Amgen)
Biological: Epoetin Hospira

First Posted Date: 2011-11-17

Last Posted Date: 2018-09-10

Lead Sponsor: Pfizer

Target Recruit Count: 612

Registration Number: NCT01473407

Locations: 🇺🇸
Clinical Research and Consulting Center, LLC, Fairfax, Virginia, United States
🇵🇷
Consolidated Medical Plaza, Caguas, Puerto Rico
🇺🇸
Internal Medicine Kidney and Hypertension Center, Norfolk, Virginia, United States

and more 80 locations

A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease

Phase 2

Completed

Conditions: Crohn's Disease

Interventions: Drug: CP-690,550

First Posted Date: 2011-11-11

Last Posted Date: 2017-10-16

Lead Sponsor: Pfizer

Target Recruit Count: 150

Registration Number: NCT01470599

Locations: 🇺🇸
Alliance Clinical Research, Oceanside, California, United States
🇺🇸
Clinical Research Of The Rockies, Lafayette, Colorado, United States
🇺🇸
Shands Endoscopy Center, Gainesville, Florida, United States

and more 71 locations

Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis

Phase 3

Completed

Conditions: Ulcerative Colitis

Interventions: Drug: CP-690,550

First Posted Date: 2011-11-11

Last Posted Date: 2021-09-17

Lead Sponsor: Pfizer

Target Recruit Count: 944

Registration Number: NCT01470612

Locations: 🇺🇸
Alabama Medical Group, P.C., Mobile, Alabama, United States
🇺🇸
Cedars Sinai Surgery Center, Los Angeles, California, United States
🇺🇸
Atlanta Center for Gastroenterology, P.C., Decatur, Georgia, United States

and more 247 locations

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Phase 1

Terminated

Conditions: Cutaneous Lupus Erythematosus

Interventions: Drug: PD-0360324
Drug: Placebo

First Posted Date: 2011-11-11

Last Posted Date: 2014-01-29

Lead Sponsor: Pfizer

Target Recruit Count: 28

Registration Number: NCT01470313

Locations: 🇲🇩
Pfizer Investigational Site, Chisinau, Moldova, Republic of

Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)

Completed

Conditions: Osteoporosis

Interventions: Drug: Bazedoxifene

First Posted Date: 2011-11-11

Last Posted Date: 2018-11-05

Lead Sponsor: Pfizer

Target Recruit Count: 3187

Registration Number: NCT01470326

A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes

Phase 1

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: PF-04991532
Drug: Placebo
Drug: PF-0499132

First Posted Date: 2011-11-10

Last Posted Date: 2013-10-30

Lead Sponsor: Pfizer

Target Recruit Count: 82

Registration Number: NCT01469065

Locations: 🇯🇵
Pfizer Investigational Site, Hachioji-shi, Tokyo, Japan

A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects

Phase 1

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Simvastatin
Drug: PF-05175157

First Posted Date: 2011-11-10

Last Posted Date: 2018-11-14

Lead Sponsor: Pfizer

Target Recruit Count: 14

Registration Number: NCT01469468

Locations: 🇺🇸
Pfizer Investigational Site, South Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy